@2024 Afarand., IRAN
ISSN: 2251-8215 Sarem Journal of Reproductive Medicine 2019;3(1):1-4
ISSN: 2251-8215 Sarem Journal of Reproductive Medicine 2019;3(1):1-4
Prevalence of Group B Streptococcus in the Vagina of 35-37-Week Pregnant Women
ARTICLE INFO
Article Type
Original ResearchAuthors
Seyedi Moghadam N. (*1)Nomanpour B. (2)
Lashgari P. ()
() MicrobiologyDepartment, Medicine Faculty, Kerman University of Medical Sciences, Kerman, Iran
(*1) Sarem Fertility & Infertility Research Center (SAFIR), Sarem Women’s Hospital, Tehran, Iran
(2) Sarem Cell Research Center (SCRC), Sarem Women Hospital, Tehran, Iran
Correspondence
Address: Sarem Women Hospital, Basij Square, Phase 3, Ekbatan Town, Tehran, Iran. Postal Code: 1396956111Phone: +98 (21) 44670888
Fax: +98 (21) 44670432
nayereh.seyedimoghaddam@gmail.com
Article History
Received: July 16, 2017Accepted: October 2, 2017
ePublished: January 4, 2019
BRIEF TEXT
Group B Streptococcus (GBS) is a gram-positive and encapsulated diplococcus, and in most cases it forms a colony in a digestive tract and human reproductive system[1]. This bacterium is an important cause of infection in newborns, pregnant women, and adults with underlying diseases[2]. In pregnant women, Streptococcus Group B, produces bacteriuria and chorioamnionitis and can cause pneumonia, meningitis, endocarditis, sepsis, and bacteremia in newborns. These infections sometimes begin the uterus[3-6]. Severe infections of pregnant women with GBS in some cases also cause failure of pregnancy[7].
Research findings have shown that the vaginal colonization of mother with GBS is infectious to infants [8]. Infection transmission from mother to fetus is transmitted vertically and usually occurs after preterm rupture of membranes[9]. However, in some cases, infections of infants with GBS occur without preterm rupture of membranes in the uterus and before the onset of labor[10]. Neonatal infections occur in two ways: 1) Early infection which occurs 24 to hours to 6 days after birth, and 2) Late infection which occurs 6 to 90 days after birth. Studies have shown that vaginal infection with GBS during pregnancy increases the risk of vertical transmission of infection to infant and the probability of late infection[11, 12]. Late infection is common in forms of meningitis, sepsis, and pneumonia in newborns and in 90% of cases, it manifests itself in the first 24 hours[13]. In studies conducted on infants whose mother with GBS-positive and not treated, in half of the cases, one complication was reported such as fetal death, infant infections and neonatal death[10]. If the infection is diagnosed during pregnancy and mothers are treated with antibiotics, the infectious outbreak decreases in the infant. In recent years, due to timely treatment, the prevalence of infection in newborns had decreased as well as neonatal lethargic complications[13].
Because of the importance of neonatal GBS infections and the lethality of septicemia caused by this bacterium, studies are needed in this regard, given that the treatment of mothers carrying these bacteria prevents infants. The purpose of this study was to determine the prevalence of B-streptococcus in pregnant women in the gestational age of 35-37 weeks of gestation.
This study is descriptive type.
In this study, during the 18 month period, from the beginning of 2011 to the middle of 2012, pregnant women who referred to Prenatal Clinic at Sarem Hospital in Tehran were investigated.
A total of 1610 women were divided into 5 groups based on their place of residence, including residents of northern Tehran, central Tehran, southern Tehran, Tehran suburb, and outside Tehran. Then, vaginal discharge was sampled from the middle third vaginal area to examine GBS with sterilized swabs and sent to microbiological lab of Sarem Hospital in tube containing sterile physiology for vaginal culture.
In the laboratory, samples were cultured on Blood Agar medium. Beta hemolysis was induced on the medium, followed by catalase and CAMP tests. Also, a range of vaginal discharge was investigated to examine the gram-positive coccus of the pair or chains by gram staining. Finally, the prevalence of GBS and its relation with demographic variables of the place of residence, level of education, occupation of pregnant women, husband›s occupation, age, frequency of pregnancy, interval between marriage and pregnancy, proper weight gain during pregnancy, abortion rate and infertility, history of underlying illness, and smoking, alcohol and drugs were studied. Data were analyzed using SPSS software.
The prevalence of GBS among pregnant women was 119 (7.4%) in the 35-37 weeks of gestation. The mean age of the subjects with GBS was 29.93±5.70 years. The minimum and maximum ages were 19 and 46 years. 96.5% of the GBS carriers were in the age range of 21-45 years old. 57% of the cases were over 30 years old and 43% were below 30 years old. Most pregnant women who came from other cities were Karaj residents. The level of education of 90% of women with GBS, was bachelor and lower (Table 1) In 97% of pregnant women carrying GBS, no underlying disease was observed, and only 3% of them had underlying disease. None of the patients consumed cigarettes, alcohol or drug. All 119 patients who were gram positive for GBS had a good weight gain during pregnancy. In GBS pregnant women, 91% had no history of infertility and only 9% had a history of infertility. Most women (48.7%) weighed less than 67 kg. In 64.7% of the cases, the interval between the marriage and the gestational age was less 5 years (Table 2).
Compared to the findings of the present study, a prevalence of GBS colonization in pregnant women in three hospital was reported to be about 20% in Taiwan in 2004-2005[14]. In another similar study in the Netherland, about 21% of pregnant women were positive for GBS bacteria[15]. Of conducted studies in Iran, one study from University of Ardabil indicated that the prevalence of GBS in vaginal and rectum samples of 420 pregnant women was about 3.5% in the 35-37 weeks. Compared to studies from other countries, it seems that the prevalence of streptococcus B in pregnant women in Iran is lower. It is important to note that our study was conducted in a private hospital and was based only on vaginal culture, while in other countries, vaginal and rectal cultivation (two samples taken together) had been studied. This difference in samples, can be justification for lower prevalence of GBS in this study, compared to other countries.
In studying the demographic findings, low level of education and living in areas outside or suburb of Tehran with a low level of health and culture were among the issues that were related to the prevalence of GBS and the need for study in these areas are emphasized. Therefore, it is necessary that the individual and environmental factors affecting the prevalence of GBS be carefully examined and more extensive studies be done with generalizability.
Because our study was conducted in a private hospital, and naturally those who come to such hospitals have higher education, culture and economic status, the findings of this study cannot be generalized to the society.
The prevalence of B group streptococcus in pregnant women is %7.4 in the week 37-35 of the pregnancy that is lower than the other countries.
Non-declared by the authors.
Non-declared by the authors.
Non-declared by the authors.
Non-declared by the authors.
TABLES and CHARTS
Show attach fileCITIATION LINKS
[1] Edwards MS, Nizet V. Group B streptococcal infections. In: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado YA, editors. Infectious Diseases of the Fetus and Newborn. 7th edition. Jacksonville, Florida: Mayo Clinic; 2011. pp. 417-55.
[2]Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. Cent Dis Control. 2010;59(10):1-36.
[3]Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States,1999-2005. J Am Med Assoc. 2008;299(17):2056-65
[4]Regan JA, Klebanoff MA, Nugent RP, Eschenbach DA, Blackwelder WC, Lou Y, et al. Colonization with group B streptococciin pregnancy and adverse outcome. Am J Obstet Gynecol. 1996;174(4):1354-60.
[5]Krohn MA, Hillier SL, Baker CJ. Maternal peripartum complications associated with vaginal group B streptococci colonization. J Infect Dis. 1999;179(6):1410-5.
[6]Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342(1):15-20.
[7]Zaleznik DF, Rench MA, Hillier S, Krohn MA, Platt R, Lee ML, et al. Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis. 2000;30(2):276-81.
[8] Valkenburg-Van Den Berg AW, Sprij AJ, Dekker FW, DÖrr PJ, Kanhai HH. Association between colonization with Group B Streptococcus and preterm delivery: A systematic review. Acta Obstet Gynecol Scand. 2009;88(9):958-67.
[9] Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol. 1989;73(4):576-82.
[10]Mittendorf R, Williams MA, Kass EH. Prevention of preterm delivery and low birth weight associated with asymptomatic bacteriuria. Clin Infect Dis. 1992;14(4):927-32
[11]Anderson BL, Simhan HN, Simons KM, Wiesenfeld HC. Untreated asymptomatic group B streptococcal bacteriuria early in pregnancy and chorioamnionitis at delivery. Am J Obstet Gynecol. 2007;196(6):524.e1-5.
[12]Wood EG, Dillon HC, Jr. A prospective study of group B streptococcal bacteriuria in pregnancy. Am J Obstet Gynecol. 1981;140(5):515-20.
[13]Persson K, Bjerre B, Elfstrom L, Polberger S, Forsgren A. Group B streptococci at delivery: high count in urine increases risk for neonatal colonization. Scand J Infect Dis. 1986;18(6):525-31.
[14]Yu Hw, Lin HC, Yang PH, Hsu CH, Hsieh WS, Tsao LY, et al. Group B streptococal in Taiwan: Maternal clononization and neonatal infection. Pediatr Neonatol. 2011;52(4):190-5.
[15]Valkenburg-Van Den Berg AW, Sprij Aj, Oostvogel PM, Mutsaers JA, Renes WB, Rosendaal FR, et al. Prevalence of colonization with group B streptococci in pregnant women of a multi-ethnic population in the netherlands. Eur J Obstet Gynecol Reprod Biol. 2006;124(2):178-83.
[2]Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. Cent Dis Control. 2010;59(10):1-36.
[3]Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States,1999-2005. J Am Med Assoc. 2008;299(17):2056-65
[4]Regan JA, Klebanoff MA, Nugent RP, Eschenbach DA, Blackwelder WC, Lou Y, et al. Colonization with group B streptococciin pregnancy and adverse outcome. Am J Obstet Gynecol. 1996;174(4):1354-60.
[5]Krohn MA, Hillier SL, Baker CJ. Maternal peripartum complications associated with vaginal group B streptococci colonization. J Infect Dis. 1999;179(6):1410-5.
[6]Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342(1):15-20.
[7]Zaleznik DF, Rench MA, Hillier S, Krohn MA, Platt R, Lee ML, et al. Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis. 2000;30(2):276-81.
[8] Valkenburg-Van Den Berg AW, Sprij AJ, Dekker FW, DÖrr PJ, Kanhai HH. Association between colonization with Group B Streptococcus and preterm delivery: A systematic review. Acta Obstet Gynecol Scand. 2009;88(9):958-67.
[9] Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol. 1989;73(4):576-82.
[10]Mittendorf R, Williams MA, Kass EH. Prevention of preterm delivery and low birth weight associated with asymptomatic bacteriuria. Clin Infect Dis. 1992;14(4):927-32
[11]Anderson BL, Simhan HN, Simons KM, Wiesenfeld HC. Untreated asymptomatic group B streptococcal bacteriuria early in pregnancy and chorioamnionitis at delivery. Am J Obstet Gynecol. 2007;196(6):524.e1-5.
[12]Wood EG, Dillon HC, Jr. A prospective study of group B streptococcal bacteriuria in pregnancy. Am J Obstet Gynecol. 1981;140(5):515-20.
[13]Persson K, Bjerre B, Elfstrom L, Polberger S, Forsgren A. Group B streptococci at delivery: high count in urine increases risk for neonatal colonization. Scand J Infect Dis. 1986;18(6):525-31.
[14]Yu Hw, Lin HC, Yang PH, Hsu CH, Hsieh WS, Tsao LY, et al. Group B streptococal in Taiwan: Maternal clononization and neonatal infection. Pediatr Neonatol. 2011;52(4):190-5.
[15]Valkenburg-Van Den Berg AW, Sprij Aj, Oostvogel PM, Mutsaers JA, Renes WB, Rosendaal FR, et al. Prevalence of colonization with group B streptococci in pregnant women of a multi-ethnic population in the netherlands. Eur J Obstet Gynecol Reprod Biol. 2006;124(2):178-83.